Evidence map›Paper›PMID 25903746›Full record

ArticleBMC nephrology2015

Rationale and design for the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) study.

Rulan S Parekh, Lucy A Meoni, Bernard G Jaar, Stephen M Sozio, Tariq Shafi, Gordon F Tomaselli, Joao A Lima, Larisa G Tereshchenko, Michelle M Estrella, W H Linda Kao

Open access · goldAbstract read
In one paragraph

Article in BMC nephrology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 37 citations in OpenAlex.

  1. Unraveling the Link between Glycerol-3-Phosphate and Fibroblast Growth Factor-23 in ESKD.Clinical journal of the American Society of Nephrology : CJASN · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Assessing arrhythmic risk in chronic kidney disease: A study of the index of cardiac-electrophysiological balance.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2025
    Article
  6. Article
  7. Functional outcomes of sleep predict cardiovascular intermediary outcomes and all-cause mortality in patients on incident hemodialysis.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2021
    Article
  8. Article
  9. Kidney international reports · 2021
    Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Frailty, body composition and the risk of mortality in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease study.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2019
    Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Rulan S ParekhDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, USA. rulan.parekh@sickkids.ca.
Lucy A MeoniDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, USA. lmeoni@jhsph.edu.
Bernard G JaarDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, USA. bjaar@jhmi.edu.
Stephen M SozioDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, USA. ssozio@jhmi.edu.
Tariq ShafiDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, USA. tshafi@jhmi.edu.
Gordon F TomaselliDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, USA. gtomasel@jhmi.edu.
Joao A LimaDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, USA. jlima@jhmi.edu.
Larisa G TereshchenkoDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, USA. tereshch@ohsu.edu.
Michelle M EstrellaDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, USA. mestrel1@jhmi.edu.
W H Linda KaoDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, USA. wkao@jhsph.edu.
Johns Hopkins Medicine · USJohns Hopkins University · US

Funding

Longitudinal Study of DialysisR01DK072367 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI PAREKH, RULAN S · 2007 to 2011
$3.7M
Novel ECG Measures and Risk of Sudden Cardiac DeathR01HL118277 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI TERESHCHENKO, LARISA GENNADIEVNA · 2013 to 2016
$1.5M
NHLBI NIH HHS R01 HL118277NIDDK NIH HHS R01 DK072367
6 · The paper itself

Abstract

backgroundSudden cardiac death occurs commonly in the end-stage renal disease population receiving dialysis, with 25% dying of sudden cardiac death over 5 years. Despite this high risk, surprisingly few prospective studies have studied clinical- and dialysis-related risk factors for sudden cardiac death and arrhythmic precursors of sudden cardiac death in end-stage renal disease. METHODS/

designWe present a brief summary of the risk factors for arrhythmias and sudden cardiac death in persons with end-stage renal disease as the rationale for the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) study, a prospective cohort study of patients recently initiated on chronic hemodialysis, with the overall goal to understand arrhythmic and sudden cardiac death risk. Participants were screened for eligibility and excluded if they already had a pacemaker or an automatic implantable cardioverter defibrillator. We describe the study aims, design, and data collection of 574 incident hemodialysis participants from the Baltimore region in Maryland, U.S.A.. Participants were recruited from 27 hemodialysis units and underwent detailed clinical, dialysis and cardiovascular evaluation at baseline and follow-up. Cardiovascular phenotyping was conducted on nondialysis days with signal averaged electrocardiogram, echocardiogram, pulse wave velocity, ankle, brachial index, and cardiac computed tomography and angiography conducted at baseline. Participants were followed annually with study visits including electrocardiogram, pulse wave velocity, and ankle brachial index up to 4 years. A biorepository of serum, plasma, DNA, RNA, and nails were collected to study genetic and serologic factors associated with disease. DISCUSSION: Studies of modifiable risk factors for sudden cardiac death will help set the stage for clinical trials to test therapies to prevent sudden cardiac death in this high-risk population.

Indexed as

AdultAgedArrhythmias, CardiacCardiovascular DiseasesCohort StudiesDeath, Sudden, CardiacFemaleHumansKidney Failure, ChronicLongitudinal StudiesMaleMiddle AgedProspective StudiesRenal DialysisRisk AssessmentRisk Factors

Identifiers

PMID25903746
PMCPMC4434806
OpenAlexW2162598993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.